Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Monkeypox Shot-Extending Approach Gets Emergency Clearance (1)

Aug. 9, 2022, 8:13 PM

US health officials are issuing emergency clearance to a technique for extending the supply of monkeypox vaccine made by Bavarian Nordic A/S amid ongoing shortages.

The action will allow the US Food and Drug Administration to “exercise additional authorities that may increase availability of vaccines to prevent monkeypox while continuing to ensure the vaccine meets high standards for safety, effectiveness and manufacturing quality,” Department of Health and Human Services Secretary Xavier Becerra said in a statement.

The Bavarian Nordic monkeypox vaccine.
Photographer: Kobi Wolf/Bloomberg

The dose-sparing strategy involves injecting the vaccine, called Jynneos, into the upper layer of the skin, rather than beneath it. The approach ...